
CAS 1122047-98-6
:Formula:C25H26ClNO6S
InChI:InChI=1S/C25H26ClNO6S/c1-32-18-7-5-6-16(12-18)21(28)15-34-22-10-11-27(14-17(22)13-23(29)30)24(25(31)33-2)19-8-3-4-9-20(19)26/h3-9,12-13,22,24H,10-11,14-15H2,1-2H3,(H,29,30)/b17-13-/t22?,24-/m0/s1
InChI key:FNCOEMFSIDGTAR-NDGGNATBSA-N
SMILES:COC1=CC=CC(=C1)C(=O)CSC\2CCN(C/C2=C/C(=O)O)[C@@H](C3=CC=CC=C3Cl)C(=O)OC
Filter by
Purity percentage
0
100
|
0
|
50
|
90
|
95
|
100
Found 10 products.
- Lower prices
- Higher prices
- Lower purities
- Higher purities
- Faster estimated delivery
cis-Clopidogrel-MP derivative
CAS:cis-Clopidogrel-MP derivativeFormula:C25H26ClNO6SPurity:99.5%Molecular weight:503.99cis-Clopidogrel-MP Derivative(Pair of Enantiomers)
CAS:Controlled ProductApplications Clopidogrel derivative. It is used as internal standard.This compound is a single pair of enantiomers but the relative stereochemistry is unknown.
References Savi, P., et al.: Biochem. Pharmacol., 44, 527 (1992), Pereillo, J., et al.: Drug Metab. Dispos., 30, 1288 (2002), Ksycinska, H., et al.: J. Pharm. Biomed. Anal., 41, 533 (2006), Farid, N., et al.: Clin. Pharmacol. Ther., 81, 735 (2007),Formula:C25H26ClNO6SColor and Shape:NeatMolecular weight:504trans-Clopidogrel-MP-13C,d3 Derivative (Mixture of Diastereomers)
CAS:Controlled ProductApplications Labelled Clopidogrel derivative.
References Savi, P., et al.: Biochem. Pharmacol., 44, 527 (1992), Pereillo, J., et al.: Drug Metab. Dispos., 30, 1288 (2002), Ksycinska, H., et al.: J. Pharm. Biomed. Anal., 41, 533 (2006), Farid, N., et al.: Clin. Pharmacol. Ther., 81, 735 (2007),Formula:C24CH23D3ClNO6SPurity:>80%Color and Shape:NeatMolecular weight:508.01(E)-MPB derivatised Clopidogrel AM metabolite hydrochloride
CAS:Formula:C25H26ClNO6SMolecular weight:504.0(E)-MPB derivatised Clopidogrel AM metabolite-[13C6] HCl
CAS:Formula:C25H26ClNO6SMolecular weight:504.0cis-Clopidogrel-MP-13C,d3 Derivative(Pair of Enantiomers)
CAS:Controlled ProductFormula:C24CH23D3ClNO6SColor and Shape:NeatMolecular weight:508.01cis-Clopidogrel-MP derivative
CAS:cis-Clopidogrel-MP derivative is an oral antiplatelet agent targeting P2Y12, derived from clopidogrel's active metabolite.Formula:C25H26ClNO6SPurity:99.35% - >99.99%Color and Shape:SolidMolecular weight:503.99






